ANKRD11

Ankyrin Repeat Domain 11; a chromatin regulator implicated in KBG syndrome and cancer

Gene Information Card

Symbol ANKRD11
Full Name Ankyrin Repeat Domain 11
Gene Type Protein coding
Chromosomal Location 16q24.3
NCBI Gene ID 29123 ncbi.nlm.nih.gov/gene/29123
Ensembl ID ENSG00000167522
UniProt ID Q6UB98
OMIM ID 611192
HGNC ID 21316
Aliases T13, ANCO1, LZ16, KANAD1

Description

ANKRD11 encodes a chromatin regulator that contains ankyrin repeats and a nuclear localization signal. It functions as a transcriptional coactivator or corepressor by interacting with histone deacetylases (HDACs) and p53. ANKRD11 is essential for normal brain development and bone formation. Heterozygous loss-of-function mutations cause KBG syndrome, and somatic alterations are observed in various cancers.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
KBG syndrome Heterozygous loss-of-function mutations in ANKRD11 lead to haploinsufficiency, disrupting chromatin regulation and causing developmental defects. ClinVar, OMIM
Intellectual disability ANKRD11 mutations impair neuronal gene expression programs, contributing to cognitive deficits. ClinVar, OMIM
Autism spectrum disorder Rare ANKRD11 variants are associated with ASD, likely through altered synaptic gene regulation. ClinVar
Breast cancer Somatic ANKRD11 mutations and copy number loss may contribute to tumor progression via p53 pathway dysregulation. COSMIC
Colorectal cancer Recurrent ANKRD11 frameshift and nonsense mutations suggest a tumor suppressor role. COSMIC

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.5 Medium
Heart 8.3 Low
Liver 6.1 Low
Kidney 9.7 Low
Testis 15.2 Medium
Lung 7.8 Low
Cell Line Expression
Cell Line nTPM Notes
HEK293 14.3 Embryonic kidney
HeLa 11.2 Cervical carcinoma
K562 9.8 Leukemia
HepG2 7.5 Hepatocellular carcinoma
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1465C>T (p.Arg489*) Nonsense <0.01% Loss-of-function; associated with KBG syndrome
c.2203C>T (p.Arg735*) Nonsense <0.01% Loss-of-function; KBG syndrome
c.5326C>T (p.Arg1776*) Nonsense <0.01% Loss-of-function; KBG syndrome
c.1234_1235del (p.Lys412fs) Frameshift <0.01% Loss-of-function; KBG syndrome
c.1A>G (p.Met1?) Start loss <0.01% Loss-of-function; KBG syndrome
Mutation functional classification

Loss of Function (LOF)

Majority of ANKRD11 disease-associated mutations are loss-of-function (nonsense, frameshift, start loss) leading to haploinsufficiency.

Gain of Function (GOF)

No well-established gain-of-function mutations reported.

Dominant Negative (DN)

Not described; haploinsufficiency is the primary mechanism.

Gene Ontology (GO)

• chromatin binding • transcription coregulator activity
• histone deacetylase binding • nucleus
• regulation of transcription by RNA polymerase II • negative regulation of cell cycle
• positive regulation of apoptotic process

Pathways

p53 signaling pathway
Chromatin modifying enzymes
Transcriptional regulation by RUNX1

Protein Summary

ANKRD11 is a 2663-amino acid nuclear protein containing multiple ankyrin repeats. It acts as a scaffold that recruits HDACs to repress transcription and also interacts with p53 to modulate apoptosis and cell cycle. The protein is widely expressed, with highest levels in brain and testis. Loss of ANKRD11 function disrupts chromatin dynamics, leading to developmental disorders and potentially contributing to tumor suppression.

Related Products

Product name Cat.No. Species Gene ID
ANKRD11 Knockout HEK293 Cell Line EDJ-KQ9000 Human 29123 Details Get a Quote
ANKRD11 Knockout A-549 Cell Line EDJ-KQ34179 Human 29123 Details Get a Quote
ANKRD11 Knockout HCT 116 Cell Line EDJ-KQ35440 Human 29123 Details Get a Quote
ANKRD11 Knockout HeLa Cell Line EDJ-KQ35441 Human 29123 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: